Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 9681 - 9688 of 11441 results
COPPA Update: FTC Provides More Flexibility on Obtaining Verifiable Parental Consent
July 22, 2014| Blog| Viewpoint
ML Strategies Posts Weekly Health Care Update on July 21, 2014
July 22, 2014| Blog| Viewpoint
Privacy Monday: July 21, 2014
July 21, 2014| Blog| Viewpoint
California Supreme Court Considers Component Parts Doctrine
July 18, 2014| Blog| Viewpoint
Changes in Breach Notification Risk Assessments Under HIPAA
July 18, 2014| Blog| Viewpoint
New Massachusetts Law Targets Self-Referrals of Clinical Laboratory Services
July 18, 2014| Blog| Viewpoint
Even in Privacy Cases, Risk of Injury Does not Always Equal Injury
July 16, 2014| Blog| Viewpoint
News & Press Releases
Venture Mega-Rounds Return to Biotech
September 26, 2024
Member Cheryl Reicin was quoted in WSJ Pro Venture Capital in an article about how venture mega rounds are becoming more frequent in the biotech industry. Specifically, Cheryl discusses the need for startups to be aware of the pressures and implications that may come from larger funding rounds.
Lenovo’s Setback in Ericsson ITC Case May Impact Other SEP Disputes
September 26, 2024
Intellectual Property Division Chair Michael Renaud was quoted by IAM in an article about the ITC case between Ericsson and Lenovo and its potential implications for FRAND negotiations. While most ITC cases involving Standard Essential Patents (SEPs) have resulted in no violation findings, this case could change that.
Mintz Ranked in 2025 Edition of Chambers Canada
September 26, 2024
Mintz announced that it has been ranked in the 2025 edition of Chambers Canada. The firm was rankedin both the Life Sciences and Cannabis Law categories. Six attorneys were also ranked in individual categories including Life Sciences, Private Equity, Investment Funds, Cannabis, and Pensions & Benefits.